Lung cancer: open trials in Saudi Arabia

5 open trials have a site in Saudi Arabia. Registry data; only the trial team decides who can take part.

NCT06667076
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 2 · Janssen Research & Development, LLC
King Faisal Specialist Hospital & Research Center, Riyadh · King Abdulaziz Medical City, Riyadh · King Saud University Medical City, Riyadh
Registry updated 2026-11-03
NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Trial Treatment · Phase 3 · Mirati Therapeutics Inc.
King Faisal Specialist Hospital, Jeddah · King Abdulaziz Medical City - National Guard Hospital, Riyadh · King Faisal Specialist Hospital and Research Center, Riyadh
Registry updated 2026-10-27
NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Trial Treatment · Phase 3 · Bristol-Myers Squibb
King Fahad Specialist Hospital - Dammam, Dammam · King Faisal Specialist Hospital, Jeddah · Riyadh
Registry updated 2026-10-23
NCT06758401
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Trial Treatment · Phase 3 · Pfizer
King Faisal Specialist Hospital and Research Center, Riyadh · King Saud University Medical City, Riyadh
Registry updated 2026-09-25
NCT05235165
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Trial Treatment · Phase 3 · Children's Oncology Group
King Faisal Specialist Hospital and Research Centre, Riyadh
Registry updated 2026-08-25

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Lung cancer: open trials in Saudi Arabia

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma